See if the Ad-AHA Stroke test reflects real-life two-handed hand use after stroke.
Official title: Beyond Observation: Validating the Ecological Relevance of the Ad-AHA Stroke Using Sensor-Based Measures
Run by KU Leuven · NCT07366697 · Data updated 2026-11-12
We will test whether the Ad-AHA Stroke test reflects how adults with chronic stroke use both hands in everyday life by comparing test scores to three days of wrist-worn sensor data.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 32 (estimated) |
| Sponsor | KU Leuven Academic / other |
| Locations | 1 site (Leuven) |
| Status | Recruiting |
| Started | December 10, 2025 |
| Main results expected | June 2028 |
| Study ends | July 2028 |
| Registry record updated | October 21, 2026 |
| Trial ID | NCT07366697 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–80, at least six months after a unilateral supratentorial stroke, living at home, with observable bimanual impairment and able to wear bilateral wrist sensors for three days are ideal candidates.
✕Probably not a fit
People with severe upper-limb impairment (FMA-UE ≤ 15), major cognitive or language barriers to following instructions, or other neurological/orthopedic conditions affecting the arms are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center, cross-sectional study at KU Leuven will compare scores on the Adult Assisting Hand Assessment - Stroke version (Ad-AHA Stroke) with real-world bimanual hand-use measured by bilateral wrist-worn accelerometers over three consecutive days. Eligible participants are community-dwelling adults 18–80 years old at least six months after a unilateral supratentorial stroke, with observable bimanual impairment but not severe upper-limb paralysis. Clinical assessment and the Ad-AHA Stroke will be performed at the clinic, and sensor data will capture day-to-day arm use in participants' home environments. The goal is to determine whether the Ad-AHA Stroke score corresponds to actual everyday bimanual performance recorded by sensors.
Why it matters
Potential benefit: If successful, this work could give clinicians a more accurate picture of how people use both hands in daily life and help tailor rehabilitation to real-world needs.
How similar studies have gone: Previous studies have used wrist accelerometers to quantify arm use after stroke and shown correlations with some clinical measures, but directly validating the Ad-AHA Stroke against multi-day real-world sensor data is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Written informed consent obtained prior to any study procedures. * Age between 18 and 80 years (inclusive). * Unilateral supratentorial stroke involving cortical or subcortical structures. * At least 6 months post-stroke at the time of inclusion. * Community-dwelling (discharged from hospital and currently living at home). * Able and willing to wear bilateral wrist-worn sensors (triaxial accelerometers) for three consecutive days. * Presence of clinically observable bimanual impairment. Exclusion Criteria: * Severe upper limb impairment, defined as a Fugl-Meyer Assessment of Upper Extremity (FMA-UE) score ≤ 15. * Severe cognitive or language comprehension impairment interfering with understanding of study instructions or task performance, as judged during screening. * Presence of other neurological or orthopedic conditions affecting upper limb function (e.g., Parkinson's disease, multiple sclerosis, severe osteoarthritis, brachial plexus injury).
Where it's running
-
Department of Rehabilitation Sciences, KU Leuven
Leuven, Belgium Recruiting
Study contacts
- Principal investigator: Geert Verheyden — KU Leuven
- Study coordinator: Geert Verheyden, PhD
- Email: geert.verheyden@kuleuven.be
- Phone: +32 16 32 91 16
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
tDCS with Constraint Therapy for better arm movement after stroke
This study tests whether adding a brief electrical brain stimulation (tDCS) to constraint-induced therapy helps people recover more upper-limb movement after a stroke.
-
Spatial StimelMD for upper-limb recovery after stroke or traumatic brain injury
This trial will test whether adding the Spatial StimelMD device to standard rehabilitation helps adults with upper-limb weakness after stroke or traumatic brain injury improve arm movement.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.